Enfusion, INC Form 4 insider transactions

Enfusion's Chief Financial Officer, Bradley Herring, sold 1,533 shares of Class A Common Stock on March 3, 2025, to cover tax withholding obligations.

Matthew Campobasso, General Counsel of Enfusion, Inc., sold 1,081 shares of Class A Common Stock on March 3, 2025, to cover tax withholding obligations.

Bronwen Bastone, Chief People Officer of Enfusion, Inc., sold 2,064 shares of Class A Common Stock on March 3, 2025, to cover tax withholding obligations.

Valeria Gutowski, Chief Accounting Officer of Enfusion, Inc., sold 540 shares of Class A Common Stock on February 28, 2025, to cover tax withholding obligations.

Chief Financial Officer Bradley Herring reports the acquisition of restricted stock units and fully vested shares of Enfusion, Inc. common stock.

Neal Pawar, Chief Operating Officer of Enfusion, Inc., reports changes in beneficial ownership of Class A Common Stock due to the grant of restricted stock units and the issuance of fully vested shares.

Oleg Movchan, CEO of Enfusion, Inc., reports acquisition of Class A Common Stock and Restricted Stock Units.

Valeria Gutowski, Chief Accounting Officer of Enfusion, Inc., reports acquisition of restricted stock units and fully vested shares.

Matthew Campobasso, General Counsel of Enfusion, Inc., reports acquisition of shares and restricted stock units.

Bronwen Bastone, Chief People Officer of Enfusion, Inc., reports acquisition of restricted stock units and fully vested shares.

Director Deirdre Somers sold 1,637 shares of Enfusion, Inc. to cover tax withholding obligations related to share issuance.

Clearwater Analytics plans to acquire Enfusion for approximately $760 million in cash and stock, aiming to create a comprehensive front-to-back platform for the investment management industry.

Clearwater Analytics is set to acquire Enfusion to create a unified, cloud-native front-to-back platform for institutional investors.

Clearwater Analytics is set to acquire Enfusion for $1.5 billion, aiming to create a comprehensive front-to-back platform for investment management.

Clearwater Analytics has announced its proposed acquisition of Enfusion, Inc., with details provided in filings with the SEC.

Clearwater Analytics will acquire Enfusion for $1.5 billion, expanding its investment management platform with front-to-back capabilities.

Clearwater Analytics will acquire Enfusion for $1.5 billion, combining their middle and back-office solutions with Enfusions front-office capabilities to create a unified investment management platform.

Enfusion's CEO, Oleg Movchan, sold shares of Class A Common Stock on January 7, 2025, to cover tax withholding obligations.

Enfusion's Chief Financial Officer, Bradley Herring, sold 4,134 shares of Class A Common Stock to cover tax withholding obligations.

Enfusion Inc.'s Chief Accounting Officer, Valeria Gutowski, sold 796 shares of Class A Common Stock to cover tax withholding obligations.

Matthew Campobasso, General Counsel of Enfusion, Inc., sold 976 shares of Class A Common Stock on January 7, 2025, to cover tax withholding obligations.

Bronwen Bastone, Chief People Officer of Enfusion, Inc., sold 809 shares of Class A Common Stock on January 7, 2025, to cover tax withholding obligations.

Enfusion's Chief Financial Officer, Bradley Herring, sold shares of Class A Common Stock on December 20, 2024, to cover tax withholding obligations.

Enfusion's Chief Operating Officer, Neal Pawar, sold a total of 48,047 Class A common stock shares to cover tax withholding obligations.

Enfusion's Chief Operating Officer, Neal Pawar, sold 19,226 shares of Class A Common Stock to cover tax withholding obligations.

Matthew Campobasso, General Counsel of Enfusion, Inc., sold 674 shares of Class A Common Stock on October 22, 2024, to cover tax withholding obligations.

Bronwen Bastone, Chief People Officer of Enfusion, Inc., sold 3,219 shares of Class A Common Stock on September 10, 2024, to cover tax withholding obligations.

Valeria Gutowski, Chief Accounting Officer of Enfusion, Inc., sold 1,258 shares of Class A Common Stock on June 18, 2024, to cover tax withholding obligations.

Matthew Campobasso, General Counsel of Enfusion, Inc., sold 1,651 shares of Class A Common Stock on June 18, 2024, to cover tax withholding obligations.

Bronwen Bastone, Chief People Officer of Enfusion, Inc., sold shares of Class A Common Stock to cover tax withholding obligations.